Zobrazeno 1 - 10
of 470
pro vyhledávání: '"avatrombopag"'
Autor:
Jain, Shivi1 Shivi_Jain@rush.edu, Gernsheimer, Terry2,3, Kolodny, Scott4, Bernheisel, Chelsea4, Vredenburg, Michael4, Panch, Sandhya R.2,3
Publikováno v:
Platelets. Dec2023, Vol. 34 Issue 1, p1-6. 6p.
Autor:
Mingot‐Castellano, Maria Eva1 (AUTHOR) mariae.mingot.sspa@juntadeandalucia.es, Bastida, Jose Maria2 (AUTHOR), Ghanima, Waleed3 (AUTHOR), Ruiz Sainz, Elena4 (AUTHOR), Nuñez Vazquez, Ramiro1 (AUTHOR), Pedrote Amador, Begoña1 (AUTHOR), Abdel‐Kader Martín, Laila5 (AUTHOR), Piquer‐Monsonis, Dolores6 (AUTHOR), Canaro, Mariana6 (AUTHOR)
Publikováno v:
British Journal of Haematology. Oct2024, Vol. 205 Issue 4, p1551-1555. 5p.
Autor:
Al‐Samkari, Hanny1,2 (AUTHOR) hal¿samkari@mgh.harvard.edu, Moore, Donald C.3 (AUTHOR)
Publikováno v:
British Journal of Haematology. Nov2024, p1. 3p.
Autor:
Arif, Abdul Rehman1 (AUTHOR), Zhao, Miaomiao2 (AUTHOR), Chen, Wenlan2 (AUTHOR), Xue, Mei2 (AUTHOR), Luo, Shanshan2 (AUTHOR), Wang, Yadan2 (AUTHOR) yadan_wang@hust.edu.cn
Publikováno v:
Platelets. 2022, Vol. 33 Issue 8, p1307-1311. 5p.
Autor:
Gao, Yanting1 (AUTHOR), Liu, Qi2 (AUTHOR), Shen, Yingying1 (AUTHOR), Li, Yuzhu2 (AUTHOR), Shao, Keding1,3 (AUTHOR), Ye, Baodong1 (AUTHOR), Shen, Yiping1 (AUTHOR), Zhou, Yuhong1 (AUTHOR) zyhblood@163.com, Wu, Dijiong1,2 (AUTHOR) wudijiong@zcmu.edu.cn
Publikováno v:
Platelets. 2022, Vol. 33 Issue 7, p1024-1030. 7p.
Autor:
Eguchi, Yuichiro1 (AUTHOR), Takahashi, Hirokazu2 (AUTHOR), Mappa, Silvia3 (AUTHOR), Santagostino, Elena4 (AUTHOR) Elena.Santagostino@sobi.com
Publikováno v:
Hepatology Research. Apr2022, Vol. 52 Issue 4, p371-380. 10p.
Autor:
Tsykunova, Galina (AUTHOR), Ghanima, Waleed (AUTHOR)
Publikováno v:
Therapeutics & Clinical Risk Management. Mar2022, Vol. 18, p273-286. 14p.
Autor:
Al‐Samkari, Hanny1 (AUTHOR) hal-samkari@mgh.harvard.edu, Nagalla, Srikanth2 (AUTHOR)
Publikováno v:
Platelets. 2022, Vol. 33 Issue 2, p257-264. 8p.
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Avatrombopag is a next-generation thrombopoietin receptor agonist approved for the treatment of thrombocytopenia in patients with chronic liver disease scheduled to undergo surgery and thrombocytopenia in patients with chronic immune thrombo
Externí odkaz:
https://doaj.org/article/54a3a4c552554706a47da868d0450874
Autor:
M. V. Maevskaya, M. Yu. Nadinskaia, E. N. Bessonova, N. I. Geyvandova, M. S. Zharkova, E. A. Kitsenko, N. V. Korochanskaya, I. A. Kurkina, A. L. Melikyan, V. G. Morozov, Yu. V. Khoronko, T. A. Deeva, K. A. Gulyaeva, V. T. Ivashkin
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 34, Iss 3, Pp 115-134 (2024)
Introduction. As a result of portal hypertension (sequestration of platelets in an enlarged spleen) and liver failure (decreased production of thrombopoietin in the liver) in liver cirrhosis, thrombocytopenia develops, which is associated with the ri
Externí odkaz:
https://doaj.org/article/b386bf93f6834d9dbfe6e6aca09034ee